openPR Logo
Press release

GILUPI participates in Consortium “European Liquid Biopsies Academy” – ELBA

01-10-2019 04:34 PM CET | Health & Medicine

Press release from: GILUPI GmbH

GILUPI participates in Consortium “European Liquid Biopsies

Blood of cancer patients contains different types of cancer-derived materials that are susceptible to detailed analysis of tumor disease: intact circulating tumor cells (CTCs), cell-free circulating tumor DNA, tumor educated platelets and extracellular vesicles. Different techniques can isolate those biomarkers and are used as diagnostic and monitoring tools for cancer treatment. These blood-based tests (also called liquid biopsy) are a sensitive and less invasive alternative or complementary approach to tissue biopsies.

The research program and educational curriculum of the European Liquid Biopsy Academy - ELBA[1], a MSCA ITN funded project (GA 765492), educates 15 early stage researchers in a range of applications and disease areas surrounding liquid biopsy. For this purpose, different companies perform trainings on state-of-the-art technologies and tools, diagnostic test development and further topics.
As part of the educational program, GILUPI, together with other companies has successfully organized the first training workshop for liquid biopsy. During this training the students got familiar with the GILUPI CellCollector® for the isolation of CTCs and were trained in using this innovative technology to analyze CTCs.

Christian Jurinke, CEO of GILUPI commented: We are proud to participate in this educational workshop and to support the ELBA organization in their goal to promote innovative medical and diagnostic applications in an international and cooperative setting.

[1] http://elba.uni-plovdiv.bg/

About GILUPI GmbH

GILUPI GmbH is a medical device company founded in 2006 with focus on the development and production of innovative products for the in vivo isolation of rare cells from the blood circulation. Currently, the main focus of GILUPI is the diagnostics market for cancer.
Individual oncological targeted therapies become increasingly important in personalized medicine. The identification of the right drug for the individual patient is todays challenge in clinical practice. To address this medical need, the GILUPI CellCollector® is used to enrich rare cells by immuno-capture directly in the patient's bloodstream. This methodology has proven to yield highest cell numbers and patient positivity rates in various cancer types. Applying diagnostic analyses ranging from immunostaining, DNA- and RNA-based methods, isolated cells can be characterized and/or analyzed down to a molecular level.
The GILUPI CellCollector® is the first in vivo CTC isolation product worldwide that is CE approved.
For further information visit www.gilupi.com

GILUPI GmbH
Hermannswerder 20a
14473 Potsdam
Germany

Tel.: +49 331-5818478-2
Fax: +49 331-5818478-0
E-Mail: info[at]gilupi.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GILUPI participates in Consortium “European Liquid Biopsies Academy” – ELBA here

News-ID: 1486613 • Views:

More Releases for European

European Gastroenterology Congress
Peers Alley Media Conferences would like to invite all the outstanding gastroenterologists, gastroenterology surgeons, scientists, academicians, young researchers, business delegates and students from all around the world to attend European Gastroenterology Congress from March 23-24, 2020 in Paris, France. This conference gives an unparalleled opportunity to network with colleagues and learn from the different leaders in gastroenterology research. This conference makes a perfect platform for global networking as it brings together the
23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
European Data Portal launched
Luxembourg – The European Commission has launched a quality-assured beta version of the European Data Portal, with more than 240,000 datasets, at the European Data Forum. An international consortium, which is led by Capgemini and of which con terra is a member, is responsible for the implementation. The European Data Portal (www.europeandataportal.eu) enables fast and simple searching of open data from 34 European countries and supports their systematic onward use.
PRISMA European Capacity Platform named Project of the Year at European Gas Conf …
The brand new PRISMA European Capacity Platform, BP’s Vice President for Shah Deniz, Al Cook, and Dr Jonathan Stern of the Oxford Institute for Energy Studies, were honoured at the annual European Gas Conference Awards at the Palais Coburg in Vienna on Wednesday evening. During the awards ceremony, which was attended by leading experts from the European gas industry, PRISMA was named Project of the Year; Al Cook was